Thyroid Cancer - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Thyroid Cancer > What Your Doctor is Reading About Thyroid Cancer > Differentiated Thyroid Carcinoma

Differentiated Thyroid Carcinoma

1. Survival and death causes in differentiated thyroid carcinoma.

Author: Eustatia-Rutten CF; Corssmit EP; Biermasz NR; Pereira AM; Romijn JA; Smit JW;
Institution: Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Journal: J Clin Endocrinol Metab. 2006 Jan;91(1):313-9. Epub 2005 Nov 1.
Abstract URL: Click here to view abstract

2. Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence.

Author: Massimino M; Collini P; Leite SF; Spreafico F; Zucchini N; Ferrari A; Mattavelli F; Seregni E; Castellani MR; Cantu G; Fossati-Bellani F; Rosai J;
Institution: Unit of Pediatrics, Istituto Nazionale Tumori, Milan, Italy. maura.massimino@istitutotumori.mi.it
Journal: Pediatr Blood Cancer. 2006 Mar;46(3):307-13.
Abstract URL: Click here to view abstract

3. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma.

Author: Monchik JM; Donatini G; Iannuccilli J; Dupuy DE;
Institution: Division of Endocrine Surgery, Brown Medical School, Rhode Island Hospital, Providence, RI 02903, USA.
Journal: Ann Surg. 2006 Aug;244(2):296-304.
Abstract URL: Click here to view abstract

4. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.

Author: Shindo M; Wu JC; Park EE; Tanzella F;
Institution: Division of Otolaryngology-Head and Neck Surgery, School of Medicine, State University of New York at Stony Brook, USA. mshindo@notes.cc.sunysb.edu
Journal: Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):650-4.
Abstract URL: Click here to view abstract

5. Surgical treatment of differentiated thyroid carcinoma: a retrospective study.

Author: Sperlongano P; Parmeggiani D; Pisaniello D; De Falco M; Sordelli I; Accardo M; Cuccurullo V; Mansi L; Tartaro GP; Barbarisi A; Avenia N; Parmeggiani U;
Institution: Department of Anaesthesiological, Surgical and Emergency Sciences, Second University of Naples, Naples, Italy. pasquale.sperlongano@unina2.it
Journal: Front Biosci. 2006 Sep 1;11:2206-12.
Abstract URL: Click here to view abstract

6. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.

Author: Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW;
Institution: Department of Endocrinology, Leiden University Medical Centre, Leiden, the Netherlands.
Journal: Clin Endocrinol (Oxf). 2006 Jun;64(6):617-24.
Abstract URL: Click here to view abstract

7. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

Author: Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M;
Institution: Institut Gustave Roussy, 94805 Villejuif Cedex, France.
Journal: J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9. Epub 2006 May 9.
Abstract URL: Click here to view abstract

8. Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome.

Author: Segal K; Shpitzer T; Hazan A; Bachar G; Marshak G; Popovtzer A;
Institution: Department of Otolaryngology-Head and Neck Surgery, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel.
Journal: Otolaryngol Head Neck Surg. 2006 May;134(5):819-22.
Abstract URL: Click here to view abstract

9. External beam radiotherapy for differentiated thyroid cancer.

Author: Meadows KM; Amdur RJ; Morris CG; Villaret DB; Mazzaferri EL; Mendenhall WM;
Institution: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
Journal: Am J Otolaryngol. 2006 Jan-Feb;27(1):24-8.
Abstract URL: Click here to view abstract

10. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Author: Lundgren CI; Hall P; Dickman PW; Zedenius J;
Institution: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. cia.ihre-lundgren@ki.se
Journal: Cancer. 2006 Feb 1;106(3):524-31.
Abstract URL: Click here to view abstract

11. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea.

Author: Keum KC; Suh YG; Koom WS; Cho JH; Shim SJ; Lee CG; Park CS; Chung WY; Kim GE;
Institution: Department of Radiation Oncology, Yonsei Cancer Center, Brain Korea 21 Project for Medical Sciences, Yonsei University, College of Medicine, Seoul, Korea.
Journal: Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):474-80. Epub 2006 Mar 20.
Abstract URL: Click here to view abstract

12. Management of well-differentiated thyroglossal remnant thyroid carcinoma: time to close the debate? Report of five new cases and proposal of a definitive algorithm for treatment.

Author: Plaza CP; Lopez ME; Carrasco CE; Meseguer LM; Perucho Ade L;
Institution: Department of Digestive and General Surgery, Regional University Hospital of Malaga Carlos Haya, Avenida de Carlos Hayas/n. C.P., Malaga, 29010, Spain. cprptot@hotmail.com
Journal: Ann Surg Oncol. 2006 May;13(5):745-52. Epub 2006 Mar 16.
Abstract URL: Click here to view abstract

13. Quality of life in cured patients with differentiated thyroid carcinoma.

Author: Hoftijzer HC; Heemstra KA; Corssmit EP; van der Klaauw AA; Romijn JA; Smit JW;
Institution: Department of Endocrinology and Metabolism, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands.
Journal: J Clin Endocrinol Metab. 2008 Jan;93(1):200-3. Epub 2007 Oct 23.
Abstract URL: Click here to view abstract

14. A new functional parameter measured at the time of ablation that can be used to predict differentiated thyroid cancer recurrence during follow-up.

Author: Verkooijen RB; Rietbergen D; Smit JW; Romijn JA; Stokkel MP;
Institution: Department of Nuclear Medicine, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands.
Journal: Eur J Endocrinol. 2007 Jan;156(1):41-7.
Abstract URL: Click here to view abstract

15. Thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma in children.

Author: Antonelli A; Miccoli P; Fallahi P; Ferrari SM; Grosso M; Boni G; Berti P;
Institution: Department of Internal Medicine, Universita di Pisa, Pisa, Italy.
Journal: Surgery. 2006 Dec;140(6):1035-41; discussion 1041-2.

16. Prognostic factors determining survival in differentiated thyroid cancer.

Author: Gulcelik MA; Gulcelik NE; Kuru B; Camlibel M; Alagol H;
Institution: Department of General Surgery, Ankara Oncology Hospital, Ankara, Turkey. mgulcelik@yahoo.com
Journal: J Surg Oncol. 2007 Dec 1;96(7):598-604.
Abstract URL: Click here to view abstract

17. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma.

Author: Balenovic A; Vlasic M; Sonicki Z; Bodor D; Kusic Z;
Institution: Department of Oncology and Nuclear Medicine, University Hospital Sestre Milosrdnice, Zagreb, Croatia. drneli@hotmail.com
Journal: Coll Antropol. 2006 Dec;30(4):743-8.
Abstract URL: Click here to view abstract

18. Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer.

Author: Cross S; Wei JP; Kim S; Brams DM;
Institution: Lahey Clinic, Burlington, Massachusetts 01803, USA.
Journal: J Surg Oncol. 2006 Dec 15;94(8):678-82.
Abstract URL: Click here to view abstract

19. Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer.

Author: Lundgren CI; Hall P; Dickman PW; Zedenius J;
Institution: Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. cia.ihre-lundgren@ki.se
Journal: Br J Surg. 2007 May;94(5):571-7.
Abstract URL: Click here to view abstract

20. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.

Author: Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK;
Institution: Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea.
Journal: Am J Clin Oncol. 2007 Feb;30(1):63-8.
Abstract URL: Click here to view abstract

21. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.

Author: Furlan JC; Bedard YC; Rosen IB;
Institution: Department of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Journal: Am Surg. 2007 May;73(5):484-91.
Abstract URL: Click here to view abstract

22. Central lymph node dissection in differentiated thyroid cancer.

Author: White ML; Gauger PG; Doherty GM;
Institution: Department of Surgery, University of Michigan, 2920 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA, gerardd@umich.edu.
Journal: World J Surg. 2007 May;31(5):895-904.
Abstract URL: Click here to view abstract

23. Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer?

Author: Carling T; Ocal IT; Udelsman R;
Institution: Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Journal: World J Surg. 2007 May;31(5):916-23.
Abstract URL: Click here to view abstract

24. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.

Author: Shammas A; Degirmenci B; Mountz JM; McCook BM; Branstetter B; Bencherif B; Joyce JM; Carty SE; Kuffner HA; Avril N;
Institution: Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Journal: J Nucl Med. 2007 Feb;48(2):221-6.
Abstract URL: Click here to view abstract

25. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.

Author: Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F;
Institution: Nuclear Medicine and Thyroid Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Journal: Clin Endocrinol (Oxf). 2007 Jun 11;.
Abstract URL: Click here to view abstract

26. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.

Author: Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC;
Institution: Institute of Clinical Physiology, National Council of Research, Pisa, Italy.
Journal: Clin Endocrinol (Oxf). 2007 Jun 6;.
Abstract URL: Click here to view abstract

27. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.

Author: Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M;
Institution: Dipartimento di Scienze Cliniche, Universita "La Sapienza", Viale del Policlinico, 155, 00161 Roma, Italy.
Journal: Biomed Pharmacother. 2007 May 22;.
Abstract URL: Click here to view abstract

28. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

Author: Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B; Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B;
Institution: Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Journal: J Nucl Med. 2007 Jun;48(6):879-88.
Abstract URL: Click here to view abstract

29. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.

Author: Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C;
Institution: Division of Pediatric General Surgery, CHU Sainte Justine, Montreal, Quebec, Canada H3T 1C5. dickens_saint-vil@ssss.gouv.qc.ca
Journal: J Pediatr Surg. 2007 May;42(5):853-6.
Abstract URL: Click here to view abstract

30. Surgical options in undifferentiated thyroid carcinoma.

Author: Lang BH; Lo CY;
Institution: Division of Endocrine Surgery, Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, SAR, China, cylo@hkucc.hku.hk.
Journal: World J Surg. 2007 May;31(5):969-77.
Abstract URL: Click here to view abstract

31. Lymph node metastases in differentiated thyroid cancer under 2 cm.

Author: Reddy RM; Grigsby PW; Moley JF; Hall BL;
Institution: Department of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Journal: Surgery. 2006 Dec;140(6):1050-4; discussion 1054-5. Epub 2006 Nov 1.
Abstract URL: Click here to view abstract